APA

Tefferi A., Li C. Y., Reeder C. B., Geyer S. M., Allmer C., Levitt R., Michalak J. C., Addo F., Krook J. E., Witzig T. E., Schaefer P. L. & Mailliard J. A. (20010816). A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia. : Leukemia.

Chicago

Tefferi A, Li C Y, Reeder C B, Geyer S M, Allmer C, Levitt R, Michalak J C, Addo F, Krook J E, Witzig T E, Schaefer P L and Mailliard J A. 20010816. A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia. : Leukemia.

Harvard

Tefferi A., Li C. Y., Reeder C. B., Geyer S. M., Allmer C., Levitt R., Michalak J. C., Addo F., Krook J. E., Witzig T. E., Schaefer P. L. and Mailliard J. A. (20010816). A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia. : Leukemia.

MLA

Tefferi A, Li C Y, Reeder C B, Geyer S M, Allmer C, Levitt R, Michalak J C, Addo F, Krook J E, Witzig T E, Schaefer P L and Mailliard J A. A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia. : Leukemia. 20010816.